Reckitt Benckiser Group PLC (RKT) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally.
Total Revenue Chart for Reckitt Benckiser Group PLC
Reckitt Benckiser Group PLC (RKT) revenue for FY2025 was GBP 14.2B, a 0.3% change from FY2024. Reckitt Benckiser Group PLC's revenue grew from GBP 3.5B in 2002 to GBP 14.2B in 2025 (311.3% over 23 years). Earnings per share grew from GBP 2.56 in 2016 to GBP 3.25 in 2022 (26.6%). Revenue compound annual growth rate: 5-year CAGR of 0.3%, 10-year CAGR of 4.8%, 20-year CAGR of 6.3%.
Total Revenue (British Pounds)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- £32.83B
- Implied Share Price
- £51.72
- Enterprise Value
- £42.02B
- Revenue (TTM)
- £13.64B
- EBITDA
- £3.59B
- Profit Margin
- 21.09%
- Trailing P/E
- 11.67
- Forward P/E
- 16.34
- Price/Book (MRQ)
- 5.76
- Price/Sales (TTM)
- 2.38
- EV/EBITDA
- 9.13
- EV/Revenue
- 3.08
- Dividend Yield
- 4.13%
- Book Value
- £8.93
- Free Cash Flow (FY2025)
- £1.76B
- Free Cash Flow Yield
- 5.36%
Snapshot as of 27th August 2026 — not point-in-time controlled, may lag the live market by a few days.